Expression profiling of angiogenic genes for the characterisation of colorectal carcinoma

European Journal of Cancer

Volumn 44, Issue 12, 2008, Pages 1761-1769

  Carrer, Alessandro ^a   Zacchigna, Serena ^a   Balani, Alessandro ^b   Pistan, Valentina ^b   Adami, Adelino ^b   Porcelli, Fabio ^b   Scaramucci, Monica ^b   Roseano, Mauro ^b   Turoldo, Angelo ^b   Prati, Maria Cristina ^c   Dell'Omodarme, Matteo ^c   Manzini, Nicolo' de ^b   Giacca, Mauro ^a,b  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c INFN SEZIONE DI PISA   (Italy)

Author keywords

Angiogenesis; Cancer; Chemokines; Expression profile; Lymphangiogenesis

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPILIN 1; OSTEOPONTIN; PLEXIN A1; PLEXIN B1; RANTES; RNA 18S; SEMAPHORIN 3A; STROMAL CELL DERIVED FACTOR 1ALPHA; THROMBOSPONDIN 1; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ARTICLE; CANCER INFILTRATION; CANCER INVASION; CARCINOGENESIS; COLON MUCOSA; COLORECTAL CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; ANGIOGENIC PROTEINS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; RNA, NEOPLASM;

EID: 48349094037     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.05.014     Document Type: Article

References (44)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics. CA Cancer J Clin 51 1 (2001) 15-36
2. Cascinu S., Georgoulias V., Kerr D., Maughan T., Labianca R., and Ychou M. Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors. Ann Oncol 14 Suppl. 2 (2003) ii25-ii29
3. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 7070 (2005) 932-936
4. Blouw B., Song H., Tihan T., et al. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4 2 (2003) 133-146
5. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 7070 (2005) 967-974
6. Vogel C., Bauer A., Wiesnet M., et al. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J Cell Physiol 212 1 (2007) 236-243
7. Alitalo K., and Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1 3 (2002) 219-227
8. Bussolino F., Serini G., Mitola S., Bazzoni G., and Dejana E. Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. EMBO Rep 2 9 (2001) 763-767
9. Gale N.W., and Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13 9 (1999) 1055-1066
10. Gale N.W., Baluk P., Pan L., et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230 2 (2001) 151-160
11. Battler A., Scheinowitz M., Bor A., et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 22 7 (1993) 2001-2006
12. Arsic N., Zentilin L., Zacchigna S., et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther 7 4 (2003) 450-459
13. Asahara T., Chen D., Takahashi T., et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83 3 (1998) 233-240
14. Thurston G., Rudge J.S., Ioffe E., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6 4 (2000) 460-463
15. Zacchigna S., Tasciotti E., Kusmic C., et al. In vivo imaging shows abnormal function of VEGF-induced vasculature. Hum Gene Ther 18 6 (2007) 515-524
16. Charalambous C., Pen L.B., Su Y.S., Milan J., Chen T.C., and Hofman F.M. Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res 65 22 (2005) 10347-10354
17. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 6729 (1999) 718-723
18. Grunewald M., Avraham I., Dor Y., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124 1 (2006) 175-189
19. Loewer A., and Lahav G. Cellular conference call: external feedback affects cell-fate decisions. Cell 124 6 (2006) 1128-1130
20. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 6 5 (2006) 392-401
21. Rangaswami H., Bulbule A., and Kundu G.C. Osteopontin: role in cell signaling and cancer progression. Trend Cell Biol 16 2 (2006) 79-87
22. Allen W.L., and Johnston P.G. Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer. Pharmacogenomics 6 6 (2005) 603-614
23. Komori T., Takemasa I., Higuchi H., et al. Identification of differentially expressed genes involved in colorectal carcinogenesis using a cDNA microarray. J Exp Clin Cancer Res 23 3 (2004) 521-527
24. Williams N.S., Gaynor R.B., Scoggin S., et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9 3 (2003) 931-946
25. Millenaar F.F., Okyere J., May S.T., van Zanten M., Voesenek L.A., and Peeters A.J. How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results. BMC Bioinformatics 7 (2006) 137
26. Pylatuik J.D., and Fobert P.R. Comparison of transcript profiling on Arabidopsis microarray platform technologies. Plant Mol Biol 58 5 (2005) 609-624
27. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 1 (1987) 156-159
28. Armitage P., Berry G., and Matthews J.N.S. Statistical methods in medical research (2002), Blackwell, Oxford, UK
29. Venables W.N., and Ripley D.B. Modern applied statistics with S (2002), Springer, New York, NY, USA
30. Guyon I., Weston J., Barnhill S., and Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn 46 1-3 (2002) 389-422
31. Guttmann-Raviv N., Kessler O., Shraga-Heled N., Lange T., Herzog Y., and Neufeld G. The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett 231 1 (2006) 1-11
32. Nguyen Q.D., Rodrigues S., Rodrigue C.M., et al. Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. Mol Cancer Ther 5 8 (2006) 2070-2077
33. Kryczek I., Wei S., Keller E., Liu R., and Zou W. Stromal derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292 3 (2006) C987-C995
34. Romero J.M., Aptsiauri N., Vazquez F., et al. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma. Tissue Antigens 68 4 (2006) 303-310
35. Rubie C., Frick V.O., Wagner M., et al. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. World J Gastroenterol 12 41 (2006) 6627-6633
36. Tuck A.B., O'Malley F.P., Singhal H., et al. Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer 79 5 (1998) 502-508
37. Chambers A.F., Wilson S.M., Kerkvliet N., O'Malley F.P., Harris J.F., and Casson A.G. Osteopontin expression in lung cancer. Lung Cancer 15 3 (1996) 311-323
38. Thalmann G.N., Sikes R.A., Devoll R.E., et al. Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 5 8 (1999) 2271-2277
39. Agrawal D., Chen T., Irby R., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94 7 (2002) 513-521
40. Yeatman T.J., and Chambers A.F. Osteopontin and colon cancer progression. Clin Exp Metastasis 20 1 (2003) 85-90
41. Kobayashi H., and Lin P.C. Angiopoietin/Tie2 signaling, tumor angiogenesis and inflammatory diseases. Front Biosci 10 (2005) 666-674
42. Armulik A., Abramsson A., and Betsholtz C. Endothelial/pericyte interactions. Circ Res 97 6 (2005) 512-523
43. Su J.L., Yen C.J., Chen P.S., et al. The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96 4 (2006) 541-545
44. Dalton W.S., and Friend S.H. Cancer biomarkers - an invitation to the table. Science 312 5777 (2006) 1165-1168